Stock Market 24 April 2026 - 25 April 2026

Academy Sports Shares Could Move 8% Next Week as Wall Street Eyes Key Figure
·····

Academy Sports Shares Could Move 8% Next Week as Wall Street Eyes Key Figure

Academy Sports and Outdoors shares fell 2.3% to $51.38 ahead of fiscal Q1 results due June 9. Options markets imply an 8.2% move on earnings, with analysts expecting EPS of 94 cents and revenue of $1.44 billion. The company raised its Q1 sales outlook to up 6%-7% and plans to update 2026 guidance. Academy opened two stores in Q1 and expects 20-25 new locations in 2026.
June 3, 2026
St. James’s Place Buyback Puts Shares in Focus Before Crucial Q1 Update
···

St. James’s Place Buyback Puts Shares in Focus Before Crucial Q1 Update

St. James’s Place Plc bought 234,313 shares for cancellation on April 23 at an average 1,280.33 pence each, leaving 519,164,225 shares in issue. The move comes days before SJP’s first-quarter business update on April 29 and its AGM. Shares closed down 2.75% at £12.58 on Friday, lagging the FTSE 100. SJP plans to return 70% of underlying cash results to shareholders from 2026.
April 25, 2026
Imperial Brands PLC Stock Faces Buyback Test After Morgan Stanley Downgrade
···

Imperial Brands PLC Stock Faces Buyback Test After Morgan Stanley Downgrade

Imperial Brands bought back 179,206 shares for £1.45 billion on Friday, following a Morgan Stanley downgrade that cut its price target to 3,050p. The company’s shares closed at 2,769p, down 0.11% after warning of market-share losses and modest profit growth. Analysts cited concerns over cash flow, next-generation product losses, and investor reaction to weaker market share.
April 25, 2026
Palantir Stock Just Got a $200 Wake-Up Call as PLTR’s AI Bet Faces Its Next Test
···

Palantir Stock Just Got a $200 Wake-Up Call as PLTR’s AI Bet Faces Its Next Test

Palantir closed Friday at $143.09, up 1.1%, with a market value of $367.9 billion, but remains down about 20% for the year. The company reports first-quarter results May 4, after securing a $300 million USDA agreement and as the Pentagon formalizes Maven. Analyst John McPeake maintained a Buy rating and $200 target, citing Palantir’s enterprise AI revenue growth. Shares are still 31% below their November 2025 high.
April 25, 2026
SSE Stock Gets New Catalyst as UK Power-Price Shake-Up Tests Utility Earnings
···

SSE Stock Gets New Catalyst as UK Power-Price Shake-Up Tests Utility Earnings

Deutsche Bank raised its price target on SSE PLC to 2,900 pence and kept a “buy” rating after the UK government proposed voluntary fixed-price power contracts and increased the Electricity Generator Levy to 55%. SSE shares closed at 2,630.50 pence Friday. The company expects 2025/26 adjusted EPS of 147-152 pence and 14.5 TWh renewable output. Preliminary results are due May 28.
April 25, 2026
UK Stock Market Today: FTSE 100 Rally Breaks as Oil Shock and BoE Warning Hit London
···

UK Stock Market Today: FTSE 100 Rally Breaks as Oil Shock and BoE Warning Hit London

The FTSE 100 fell 0.8% to 10,379.08 on Friday, ending a four-week winning streak as rising oil prices and Middle East tensions hit sentiment. Banks and drugmakers led losses, with AstraZeneca down 3.7% and Barclays off 0.9%. Retail sales rose 0.7% in March, but gains were driven by fuel buying. Mondi shares plunged 11.1% after warning of higher costs and announcing 450 job cuts in Europe.
April 25, 2026
Australia Stock Market This Week: ASX 200’s Worst Week Since March as Oil Shock, Fortescue Selloff Bite
·········

Australia Stock Market This Week: ASX 200’s Worst Week Since March as Oil Shock, Fortescue Selloff Bite

The S&P/ASX 200 dropped 1.8% for the week, closing Friday at 8,786.50, its sharpest decline since mid-March. Cochlear plunged 40.7% after slashing its profit outlook, while CSL hit a multi-year low following the end of a U.S. military vaccine mandate. Miners also fell, offsetting gains in energy stocks driven by Middle East tensions.
April 25, 2026
British American Tobacco Shares Rise After Morgan Stanley Makes BAT Its Top European Tobacco Pick
···

British American Tobacco Shares Rise After Morgan Stanley Makes BAT Its Top European Tobacco Pick

British American Tobacco shares rose 1.97% to 4,302p late Friday after Morgan Stanley double-upgraded the stock to overweight and named it its top European tobacco pick, raising the price target to 4,900p. The upgrade comes as UK lawmakers passed a bill tightening tobacco and vaping rules and raising the legal buying age, while BAT continues buybacks and reports growth in newer nicotine products.
April 25, 2026
UK & AU Stock Market Today: Live Updates 25.04.2026
······

UK & AU Stock Market Today: Live Updates 25.04.2026

LIVEMarkets rolling coverageStarted: April 25, 2026, 12:00 AM EDTUpdated: April 25, 2026, 11:59 PM EDT Remote Indigenous Towns in Australia Invest in Solar Microgrids to Cut Diesel Dependence April 25, 2026, 11:33 PM EDT. Indigenous communities in remote Australia are moving towards energy sovereignty by investing in solar and battery microgrids. Djarindjin, home to nearly 400 Bardi and Jawi people, plans a multimillion-dollar project to supply 80% of its power from renewables, reducing reliance on government-supplied diesel generators. The project, Aalga Goorlil, signals a shift towards local ownership and control amid rising fuel costs exacerbated by global conflicts. Meanwhile, the
April 25, 2026
Macquarie Group Stock Watch: 5.26% Regis Resources Stake Lands as UBS Turns Cautious
···

Macquarie Group Stock Watch: 5.26% Regis Resources Stake Lands as UBS Turns Cautious

Macquarie Group disclosed a 5.26% voting stake in Regis Resources, crossing Australia’s substantial-holder threshold on April 21, according to a late-Friday filing. The move comes ahead of Macquarie’s May 8 results and after its shares retreated from a 52-week high. Macquarie also ceased to be a substantial holder in Ventia Services Group on the same date. UBS downgraded Macquarie to Neutral earlier in the week.
April 25, 2026
ConvaTec Shares Drop Again as Wound-Care Warning Puts 2026 Growth Plan in Focus
···

ConvaTec Shares Drop Again as Wound-Care Warning Puts 2026 Growth Plan in Focus

Convatec shares fell 1.69% to £2.21 in London Friday, closing nearly 30% below their 52-week high as investors reacted to weakness in the wound-care market. The drop followed Coloplast’s cut to its 2025/26 outlook and a DKK 3 billion impairment on its Kerecis business. Convatec expects InnovaMatrix revenue to fall to $20 million in 2026 due to U.S. Medicare changes.
April 24, 2026
Bunzl Shares Rise Again After Q1 Update: What the North America Rebound Means
····

Bunzl Shares Rise Again After Q1 Update: What the North America Rebound Means

Bunzl shares closed up 0.91% at 2,447 pence in London on Friday, rising for a third straight session after the company maintained its 2026 outlook. First-quarter revenue rose 1.5% at constant exchange rates, while underlying revenue climbed 2.0%. North America, Bunzl’s largest region, saw underlying growth slightly ahead of the group. Adjusted operating profit met management’s expectations.
April 24, 2026
Australia Stock Market Today: ASX 200 Slides Again as Oil Shock Hits Miners, Banks and Risk Appetite
···

Australia Stock Market Today: ASX 200 Slides Again as Oil Shock Hits Miners, Banks and Risk Appetite

The S&P/ASX 200 closed down 0.08% at 8,786.50 on Friday, capping a 1.8% weekly drop—its worst since mid-March. Miners and gold stocks fell, offsetting gains in energy and utilities. Fortescue dropped 5.7% after cutting Iron Bridge guidance and announcing a $680 million Pilbara investment. Brent crude traded above $105 a barrel, fueling investor caution amid Middle East tensions.
April 24, 2026
1 … 35 36 37 38 39 … 127

Stock Market Today

  • Top Brokers Recommend 3 ASX Shares: 4DMedical, Coles Group, Pro Medicus
    June 3, 2026, 1:27 AM EDT. Leading Australian brokers have highlighted three ASX shares as buys: 4DMedical Ltd (4DX), Coles Group Ltd (COL), and Pro Medicus Ltd (PME). Bell Potter retains a speculative buy on 4DMedical, raising its price target to $6.00, citing promising clinical studies in pulmonary embolism diagnosis. Macquarie keeps an outperform rating on Coles with a $24.10 target, favoring supermarkets amid weak consumer spending, considering grocery demand more resilient. Pro Medicus also retains an outperform call despite trimming its price target to $221.00, following multiple contract wins enhancing its market position. Shares trade at $3.83 (4DMedical), $21.48 (Coles), and $159.12 (Pro Medicus) respectively, showing varied upside potential for investors over the next year.